Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Su

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
JAAD International|August 19, 2021
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)Clare L Rogers, Matthew Gibson, Johannes S Kern, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 29, 2022
Establishing subclasses of childhood eczema, their risk factors and prognosisDiego J Lopez, Caroline J Lodge, Dinh S Bui, et al.
The Lancet. Child & Adolescent Health|June 3, 2026
Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trialSonja Molin, Eulalia Baselga, Francisco J Navarro-Triviño, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 27, 2023
Atopic dermatitis: A global health perspectiveOusmane Faye, Carsten Flohr, Kenji Kabashima, et al.
The Australasian Journal of Dermatology|May 14, 2024
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patientsPeter Foley, Patrick D Mahar, Saxon D Smith, et al.
Occupational and Environmental Medicine|October 5, 2023
Exploration of associations between occupational exposures and current adult eczemaDiego J Lopez, Sheikh Alif, Shyamali Dharmage, et al.
American Journal of Clinical Dermatology|August 25, 2023
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2Gil Yosipovitch, Melinda J Gooderham, Sonja Ständer, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2024
Air pollution is associated with persistent peanut allergy in the first 10 yearsDiego J Lopez, Caroline J Lodge, Dinh S Bui, et al.
Allergy|February 18, 2021
Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adultsDiego J Lopez, Caroline J Lodge, Dinh S Bui, et al.
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
JAAD International|August 19, 2021
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)Clare L Rogers, Matthew Gibson, Johannes S Kern, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 29, 2022
Establishing subclasses of childhood eczema, their risk factors and prognosisDiego J Lopez, Caroline J Lodge, Dinh S Bui, et al.
The Lancet. Child & Adolescent Health|June 3, 2026
Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trialSonja Molin, Eulalia Baselga, Francisco J Navarro-Triviño, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 27, 2023
Atopic dermatitis: A global health perspectiveOusmane Faye, Carsten Flohr, Kenji Kabashima, et al.
The Australasian Journal of Dermatology|May 14, 2024
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patientsPeter Foley, Patrick D Mahar, Saxon D Smith, et al.
Occupational and Environmental Medicine|October 5, 2023
Exploration of associations between occupational exposures and current adult eczemaDiego J Lopez, Sheikh Alif, Shyamali Dharmage, et al.
American Journal of Clinical Dermatology|August 25, 2023
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2Gil Yosipovitch, Melinda J Gooderham, Sonja Ständer, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2024
Air pollution is associated with persistent peanut allergy in the first 10 yearsDiego J Lopez, Caroline J Lodge, Dinh S Bui, et al.
Allergy|February 18, 2021
Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adultsDiego J Lopez, Caroline J Lodge, Dinh S Bui, et al.
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
Pageof 5